StockData
Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc. (CRBU) stock

CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3074% below fair value
$0.34−0.01 (-3.43%)

Close on Nov 17, 2026Market cap $36.53MP/E –Yield –

Caribou Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Caribou Biosciences

Caribou Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Caribou Biosciences figures

See a number that looks wrong?